Selected Publications

  1. Stansell E, Panico M, Canis K, Pang PC, Bouche L, Binet D, O'Connor MJ, Chertova E, Bess J, Lifson JD, Haslam SM, Morris HR, Desrosiers RC, Dell A. 2015. Gp120 on HIV-1 Virions Lacks O-Linked Carbohydrate. PLoS One 10:e0124784.
  2. Miller E, Spadaccia M, Sabado R, Chertova E, Bess J, Trubey CM, Holman RM, Salazar A, Lifson J, Bhardwaj N. 2015. Autologous aldrithiol-2-inactivated HIV-1 combined with polyinosinic-polycytidylic acid-poly-l-lysine carboxymethylcellulose as a vaccine platform for therapeutic dendritic cell immunotherapy. Vaccine 33:388-395.
  3. Frank GA, Narayan K, Bess JW, Jr., Del Prete GQ, Wu X, Moran A, Hartnell LM, Earl LA, Lifson JD, Subramaniam S. 2015. Maturation of the HIV-1 core by a non-diffusional phase transition. Nat Commun 6:5854.
  4. Jalah R, Kulkarni V, Patel V, Rosati M, Alicea C, Bear J, Yu L, Guan Y, Shen X, Tomaras GD, Labranche C, Montefiori DC, Prattipati R, Pinter A, Bess J, Jr., Lifson JD, Reed SG, Sardesai NY, Venzon DJ, Valentin A, Pavlakis GN, Felber BK. 2014. DNA and protein co-immunization improves the magnitude and longevity of humoral immune responses in macaques. PLoS One 9:e91550.
  5. Patel V, Jalah R, Kulkarni V, Valentin A, Rosati M, Alicea C, von Gegerfelt A, Huang W, Guan Y, Keele BF, Bess JW, Jr., Piatak M, Jr., Lifson JD, Williams WT, Shen X, Tomaras GD, Amara RR, Robinson HL, Johnson W, Broderick KE, Sardesai NY, Venzon DJ, Hirsch VM, Felber BK, Pavlakis GN. 2013. DNA and virus particle vaccination protects against acquisition and confers control of viremia upon heterologous simian immunodeficiency virus challenge. Proc Natl Acad Sci U S A 110:2975-2980.
  6. Del Prete GQ, Kearney MF, Spindler J, Wiegand A, Chertova E, Roser JD, Estes JD, Hao XP, Trubey CM, Lara A, Lee K, Chaipan C, Bess JW, Jr., Nagashima K, Keele BF, Pung R, Smedley J, Pathak VK, Kewalramani VN, Coffin JM, Lifson JD. 2012. Restricted Replication of Xenotropic Murine Leukemia Virus-Related Virus in Pigtailed Macaques. J Virol doi:JVI.06886-11 [pii] 10.1128/JVI.06886-11.
  7. Del Prete GQ, Kearney MF, Spindler J, Wiegand A, Chertova E, Roser JD, Estes JD, Hao XP, Trubey CM, Lara A, Lee K, Chaipan C, Bess JW, Jr., Nagashima K, Keele BF, Macallister R, Smedley J, Pathak VK, Kewalramani VN, Coffin JM, Lifson JD. 2012. Restricted replication of xenotropic murine leukemia virus-related virus in pigtailed macaques. J Virol 86:3152-3166.
  8. White TA, Bartesaghi A, Borgnia MJ, de la Cruz MJ, Nandwani R, Hoxie JA, Bess JW, Lifson JD, Milne JL, Subramaniam S. 2011. Three-dimensional structures of soluble CD4-bound states of trimeric simian immunodeficiency virus envelope glycoproteins determined by using cryo-electron tomography. J Virol 85:12114-12123.
  9. White TA, Bartesaghi A, Borgnia MJ, Meyerson JR, de la Cruz MJ, Bess JW, Nandwani R, Hoxie JA, Lifson JD, Milne JL, Subramaniam S. 2010. Molecular architectures of trimeric SIV and HIV-1 envelope glycoproteins on intact viruses: strain-dependent variation in quaternary structure. PLoS Pathog 6:e1001249.
  10. Gherghe C, Lombo T, Leonard CW, Datta SA, Bess JW, Jr., Gorelick RJ, Rein A, Weeks KM. 2010. Definition of a high-affinity Gag recognition structure mediating packaging of a retroviral RNA genome. Proc Natl Acad Sci U S A 107:19248-19253.
  11. Felts RL, Narayan K, Estes JD, Shi D, Trubey CM, Fu J, Hartnell LM, Ruthel GT, Schneider DK, Nagashima K, Bess JW, Jr., Bavari S, Lowekamp BC, Bliss D, Lifson JD, Subramaniam S. 2010. 3D visualization of HIV transfer at the virological synapse between dendritic cells and T cells. Proc Natl Acad Sci U S A 107:13336-13341.
  12. Watts JM, Dang KK, Gorelick RJ, Leonard CW, Bess JW, Jr., Swanstrom R, Burch CL, Weeks KM. 2009. Architecture and secondary structure of an entire HIV-1 RNA genome. Nature 460:711-716.
  13. Vagenas P, Williams VG, Piatak M, Jr., Bess JW, Jr., Lifson JD, Blanchard JL, Gettie A, Robbiani M. 2009. Tonsillar application of AT-2 SIV affords partial protection against rectal challenge with SIVmac239. J Acquir Immune Defic Syndr 52:433-442.
  14. Trapp S, Derby NR, Singer R, Shaw A, Williams VG, Turville SG, Bess JW, Jr., Lifson JD, Robbiani M. 2009. Double-stranded RNA analog poly(I:C) inhibits human immunodeficiency virus amplification in dendritic cells via type I interferon-mediated activation of APOBEC3G. J Virol 83:884-895.
  15. Krishnamoorthy L, Bess JW, Jr., Preston AB, Nagashima K, Mahal LK. 2009. HIV-1 and microvesicles from T cells share a common glycome, arguing for a common origin. Nat Chem Biol 5:244-250.
  16. Vachot L, Williams VG, Bess JW, Jr., Lifson JD, Robbiani M. 2008. Candida albicans-induced DC activation partially restricts HIV amplification in DCs and increases DC to T-cell spread of HIV. J Acquir Immune Defic Syndr 48:398-407.
  17. Turville SG, Aravantinou M, Miller T, Kenney J, Teitelbaum A, Hu L, Chudolij A, Zydowsky TM, Piatak M, Jr., Bess JW, Jr., Lifson JD, Blanchard J, Gettie A, Robbiani M. 2008. Efficacy of Carraguard-based microbicides in vivo despite variable in vitro activity. PLoS One 3:e3162.
  18. Frank I, Stossel H, Gettie A, Turville SG, Bess JW, Jr., Lifson JD, Sivin I, Romani N, Robbiani M. 2008. A fusion inhibitor prevents spread of immunodeficiency viruses, but not activation of virus-specific T cells, by dendritic cells. J Virol 82:5329-5339.
  19. Sougrat R, Bartesaghi A, Lifson JD, Bennett AE, Bess JW, Zabransky DJ, Subramaniam S. 2007. Electron tomography of the contact between T cells and SIV/HIV-1: implications for viral entry. PLoS Pathog 3:e63.